| Jakavi EU/1/12/773/001 |
Ruxolitinib |
Novartis Europharm Limited |
— |
| Jakavi EU/1/12/773/002 |
Ruxolitinib |
Novartis Europharm Limited |
— |
| Jakavi 10 mg tablets EU/1/12/773/013-016 |
Ruxolitinib |
Novartis Europharm Limited |
— |
| Jakavi 20 mg tablets EU/1/12/773/003 |
Ruxolitinib |
Novartis Europharm Limited |
— |
| Jakavi 5 mg tablets EU/1/12/773/004-006 |
Ruxolitinib phosphate |
Novartis Europharm Limited |
— |
| Jakavi 5mg/ml Oral solution EU/1/12/773/017 |
Ruxolitinib phosphate |
Novartis Europharm Limited |
— |
| Jalra 50 mg tablets EU/1/08/485/1-11 |
Vildagliptin |
Novartis Europharm Limited |
— |
| Janumet 50 mg/1000 mg film-coated tablets EU/1/08/455/008-014 |
Sitagliptin phosphate, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| Janumet 50 mg/850 mg film-coated tablets EU/1/08/455/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride |
Merck Sharp & Dohme BV, |
— |
| Januvia 100 mg film-coated tablets EU/1/07/383/13-18 |
Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |
| Januvia 25 mg film-coated tablets EU/1/07/383/1-6 |
Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV, |
— |
| Januvia 50 mg film-coated tablets EU/1/07/383/7-12 |
Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |
| Jardiance 10 mg film-coated tablets EU/1/14/930/010-018 |
Empagliflozin |
Boehringer Ingelheim International GmbH |
— |
| Jardiance 25 mg film-coated tablets EU/1/14/930/001-009 |
Empagliflozin |
Boehringer Ingelheim International GmbH |
— |
| Javlor 25 mg/mL concentrate for solution for infusion EU/1/09/550/1-12 |
Vinflunine ditartrate |
Pierre Fabre Medicament |
— |
| Jaydess 13.5 mg intrauterine delivery system PA1410/068/001 |
Levonorgestrel |
Bayer Limited |
Marketed |
| Jayempi 10 mg/ml oral suspension EU/1/21/1557/001 |
Azathioprine |
Lipomed GmbH |
— |
| Jaypirca 100 mg film-coated tablets EU/1/23/1738/004-009 |
Pirtobrutinib |
Eli Lilly Nederland B.V. |
— |
| Jaypirca 50 mg film-coated tablets EU/1/23/1738/001-003 |
Pirtobrutinib |
Eli Lilly Nederland B.V. |
— |
| JEMPERLI 500 mg concentrate for solution for infusion EU/1/21/1538/001 |
Dostarlimab |
GlaxoSmithKline Trading Services Limited |
— |
| Jentadueto 2.5 mg/1000 mg film-coated tablets EU/1/12/780/015-028 |
Metformin, Linagliptin |
Boehringer Ingelheim International GmbH |
— |
| Jentadueto 2.5 mg/850 mg film-coated tablets EU/1/12/780/001-014 |
Linagliptin, Metformin |
Boehringer Ingelheim International GmbH |
— |
| JERAYGO 12.5 mg film-coated tablets EU/1/24/1818/001-002 |
Aprocitentan |
Idorsia Pharmaceuticals Deutschland GmbH |
— |
| JERAYGO 25 mg film-coated tablets EU/1/24/1818/003-004 |
Aprocitentan |
Idorsia Pharmaceuticals Deutschland GmbH |
— |
| JEVTANA 60 mg concentrate and solvent for solution for infusion EU/1/11/676/001 |
Cabazitaxel |
Sanofi Winthrop Industrie |
— |
| Jext 150 micrograms solution for injection in pre-filled pen PA1255/006/001 |
Adrenaline |
ALK-Abello A/S |
Marketed |
| Jext 300 micrograms solution for injection in pre-filled pen PA1255/006/002 |
Adrenaline |
ALK-Abello A/S |
Marketed |
| Jinarc 15 mg tablets EU/1/15/1000/001-002 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Jinarc 15 mg tablets + Jinarc 45 mg tablets EU/1/15/1000/005-007 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Jinarc 30 mg tablets EU/1/15/1000/003-004 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Jinarc 30 mg tablets + Jinarc 60 mg tablets EU/1/15/1000/008-010 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Jinarc 30 mg tablets + Jinarc 90 mg tablets EU/1/15/1000/011-013 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Jivi 1000 IU powder and solvent for solution for injection EU/1/18/1324/003 |
DAMOCTOCOG ALFA PEGOL |
Bayer AG |
— |
| Jivi 2000 IU powder and solvent for solution for injection EU/1/18/1324/004 |
DAMOCTOCOG ALFA PEGOL |
Bayer AG |
— |
| Jivi 250 IU powder and solvent for solution for injection EU/1/18/1324/001 |
DAMOCTOCOG ALFA PEGOL |
Bayer AG |
— |
| Jivi 3000 IU powder and solvent for solution for injection EU/1/18/1324/005 |
DAMOCTOCOG ALFA PEGOL |
Bayer AG |
— |
| Jivi 4000 IU powder and solvent for solution for injection EU/1/18/1324/011-012 |
DAMOCTOCOG ALFA PEGOL |
Bayer AG |
— |
| Jivi 500 IU powder and solvent for solution for injection EU/1/18/1324/002 |
DAMOCTOCOG ALFA PEGOL |
Bayer AG |
— |
| Jorveza 0.5 mg orodispersible tablets EU/1/17/1254/007-011 |
Budesonide |
Dr. Falk Pharma GmbH |
— |
| Jorveza 1 mg orodispersible tablets EU/1/17/1254/001-005 |
Budesonide |
Dr. Falk Pharma GmbH |
— |
| Jubbonti 60 mg solution for injection in pre-filled syringe EU/1/24/1813/001 |
Denosumab |
Sandoz GmbH |
— |
| Jubereq 120 mg solution for injection EU/1/25/1921/001-003 |
Denosumab |
Accord Healthcare S.L.U. |
— |
| Juluca 50 mg/25 mg film-coated tablets EU/1/18/1282/001-002 |
Dolutegravir, Rilpivirine hydrochloride, Sodium starch glycolate ep, Iron oxide yellow (E172) |
ViiV Healthcare BV |
— |
| Junior Parapaed Paracetamol Oral Suspension 120 mg/5 ml PA0281/002/001 |
Paracetamol |
Pinewood Laboratories Ltd |
Marketed |
| Junod 60 mg solution for injection in pre-filled syringe EU/1/25/1933/001 |
Denosumab |
Gedeon Richter Plc |
— |
| Junyelt, Concentrate for solution for infusion PA1968/006/001 |
Zinc gluconate, Copper gluconate, Manganese Gluconate, Potassium iodide, Sodium selenite |
Laboratoire Aguettant |
Marketed |
| Jylamvo 2 mg/ml oral solution EU/1/17/1172/001 |
Methotrexate |
Oresund Pharma ApS |
— |
| Jyseleca 100 mg film-coated tablets EU/1/20/1480/001-002 |
Filgotinib maleate |
Alfasigma S.p.A |
— |
| Jyseleca 200 mg film-coated tablets EU/1/20/1480/003-004 |
Filgotinib maleate |
Alfasigma S.p.A |
— |